The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 27th 2025
The FDA's approvals follows new COVID-19 guidance announced by the commissioner of the agency in May 2025, focusing future approvals on older adults.
Mylan Board Unanimously Rejects Unsolicited Expression of Interest from Teva
April 27th 2015Board concludes that approach grossly undervalues Mylan, includes low-quality, high-risk Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of delivering shareholder value.
Read More